NervGen Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for NervGen Pharma (NGEN).

Price Target Range — 2 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOutperform# Analysts2Avg. Consensus PT$13Upside to Avg. PT+622.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 14, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$18→$15
Jul 13, 2026	Leerink Partners	Marc Goodman	Initiate	Outperform	$10
Apr 27, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$18

More with Benzinga EdgeGet Access

Analyst Ratings News

Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday

Summary: Wall Street analysts changed rating for JAZZ, AFRM, MNDY, NGEN, FCEL, RRR, ABNB, KARO. See how other analysts view these stocks.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on NervGen Pharma, Lowers Price Target to $15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains NervGen Pharma (NASDAQ:NGEN) with a Buy and lowers the price target from $18 to $15.

Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On NervGen Pharma with Outperform Rating, Announces Price Target of $10

Leerink Partners analyst Marc Goodman initiates coverage on NervGen Pharma (NASDAQ:NGEN) with a Outperform rating and announces Price Target of $10.

Benzinga Newsdesk

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrades/downgrades/initiations, on Benzinga.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On NervGen Pharma with Buy Rating, Announces Price Target of $18

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on NervGen Pharma (NASDAQ:NGEN) with a Buy rating and announces Price Target of $18.

Benzinga Newsdesk

NervGen Pharma Corp

뉴스

파트너 / 기고자

벤징가 글로벌

NervGen Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday

PRO
HC Wainwright & Co. Maintains Buy on NervGen Pharma, Lowers Price Target to $15

PRO
Leerink Partners Initiates Coverage On NervGen Pharma with Outperform Rating, Announces Price Target of $10

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
HC Wainwright & Co. Initiates Coverage On NervGen Pharma with Buy Rating, Announces Price Target of $18

People Also Watch

People Also Watch

NervGen Pharma Corp

뉴스

파트너 / 기고자

벤징가 글로벌

NervGen Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday

PROHC Wainwright & Co. Maintains Buy on NervGen Pharma, Lowers Price Target to $15

PROLeerink Partners Initiates Coverage On NervGen Pharma with Outperform Rating, Announces Price Target of $10

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROHC Wainwright & Co. Initiates Coverage On NervGen Pharma with Buy Rating, Announces Price Target of $18

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on NervGen Pharma, Lowers Price Target to $15

PRO
Leerink Partners Initiates Coverage On NervGen Pharma with Outperform Rating, Announces Price Target of $10

PRO
HC Wainwright & Co. Initiates Coverage On NervGen Pharma with Buy Rating, Announces Price Target of $18